Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR

Delayed Quote. Delayed  - 09/28 05:12:27 pm
21.8132 USD   -1.12%
09/27 ACORDA THERAPEU : The Arbitral Tribunal Has Confirmed Acorda Therape..
09/26 ACORDA THERAPEU : THE ARBITRAL TRIBUNAL HAS CONFIRMED ACORDA THERAPE..
09/15 ACORDA THERAPEU : Launches “The Many Faces of OFF” Faceb..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/22/2016 09/23/2016 09/26/2016 09/27/2016 09/28/2016 Date
27.22(c) 27.28(c) 22.99(c) 22.06(c) 21.8132 Last
636 552 537 126 2 842 714 1 321 409 212 015 Volume
+0.55% +0.22% -15.73% -4.05% -1.12% Change
More quotes
Financials ($)
Sales 2016 511 M
EBIT 2016 0,30 M
Net income 2016 -40,1 M
Finance 2016 93,5 M
Yield 2016 -
Sales 2017 566 M
EBIT 2017 21,4 M
Net income 2017 -22,7 M
Finance 2017 77,0 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 1,81x
EV / Sales2017 1,66x
Capitalization 1 018 M
More Financials
Company
Acorda Therapeutics, Inc. develops and markets therapeutic products for nervous system disorders.The company's two main products are Ampyra and Zanaflex Capsules.The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short... 
More about the company
Surperformance© ratings of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACORDA THERAPEUTICS INC
09/27 ACORDA THERAPEUTICS : The Arbitral Tribunal Has Confirmed Acorda Therapeutics, I..
09/26 ACORDA THERAPEUTICS : THE ARBITRAL TRIBUNAL HAS CONFIRMED ACORDA THERAPEUTICS, I..
09/15 ACORDA THERAPEUTICS : Launches “The Many Faces of OFF” Facebook Page..
08/18 ACORDA THERAPEUTICS : Patent Issued for Compositions and Methods of Using Chondr..
08/15 ACORDA THERAPEUTICS INC : Other Events (form 8-K)
08/11 ACORDA THERAPEUTICS : Patent Issued for Compositions and Methods of Using Chondr..
08/04 ACORDA THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
08/04 ACORDA THERAPEUTICS : Assigned Patent
08/03 ACORDA THERAPEUTICS INC : Other Events (form 8-K)
07/28 ACORDA THERAPEUTICS INC : Results of Operations and Financial Condition, Financi..
More news
Sector news : Bio Therapeutic Drugs
09/27DJAMGEN : Myeloma Treatment Study Fails to Meet Primary Endpoint
09/26DJPfizer Throws Out Plan to Split Into Two Companies
09/26DJSANOFI : FDA Accepts Sanofi's, Regeneron's Dermatitis Treatment for Priority Rev..
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
09/26 Midday Gainers / Losers
09/26 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
09/23 After Hours Gainers / Losers
08/24 Acorda Therapeutics Can Deliver Sustained Growth
08/13 Tracking Seth Klarman's Baupost Group Holdings - Q2 2016 Update
Advertisement
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Technical analysis trends ACORDA THERAPEUTI...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 39,6 $
Spread / Average Target 80%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Ronald Cohen President, Chief Executive Officer & Director
David Lawrence Head-Business Operations
Michael W. Rogers Chief Financial Officer
Andrew R. Blight Chief Scientific Officer
Anthony O. Caggiano Vice President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ACORDA THERAPEUTICS IN..-48.43%1 061
AMGEN, INC.5.73%129 863
GILEAD SCIENCES, INC.-21.68%106 391
CELGENE CORPORATION-10.32%82 402
REGENERON PHARMACEUTIC..-22.37%42 552
VERTEX PHARMACEUTICALS..-29.17%21 876
More Results